Loncar Cancer Immunotherapy ETF (CNCR) Climbed 5.38% or 1.43 To Price $27.99 On Monday
Loncar Cancer Immunotherapy ETF (CNCR) climbed 5.38% or 1.43 to $27.99. It is around 47460 shares traded, which is 348.56% compare to the average total volume 13616. The year to date change is 8.5%. The 52 week price range is…